Scribe lands $25m to advance heart disease gene therapies (opens in new tab)

New funding will help advance two one-time CRISPR treatments for inherited cardiovascular risks toward human trials. Think about finding out that your risk of heart disease was largely written into your DNA long before you were born. Now imagine addressing that risk not with a lifetime of pills, injections or restrictive diets, but with a […] The post appeared first on <a href="